Drugs Made In America Acquisition (DMAAR) Non Operating Income (2025)
Drugs Made In America Acquisition (DMAAR) posted Non Operating Income of $2.3 million for Q4 2025, down 5.96% on a QoQ basis from $2.4 million in Q3 2025.
Drugs Made In America Acquisition (DMAAR) Non Operating Income (2025) Analysis & Trends
Drugs Made In America Acquisition's Non Operating Income history runs 1 years deep, the most recent figure standing at $2.3 million for Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | SIM Acquisition Corp. I | 314.52 Mn | 314.52 Mn | - | 2.16 Mn |
| 2 | Thayer Ventures Acquisition | 208.29 Mn | 208.29 Mn | - | - |
| 3 | Newbury Street II Acquisition | 185.26 Mn | 185.26 Mn | - | 1.61 Mn |
| 4 | Dynamix | 178.78 Mn | 178.78 Mn | - | 2.16 Mn |
| 5 | Hallmark Venture | 103.01 Mn | 102.76 Mn | - | -234,925.00 |
| 6 | Voyager Acquisition | 99.58 Mn | 99.45 Mn | - | - |
| 7 | Gores Holdings X | 95.80 Mn | 95.37 Mn | - | - |
| 8 | Archimedes Tech SPAC Partners | 89.88 Mn | 89.88 Mn | - | 2.38 Mn |
| 9 | Cohen Circle Acquisition | 80.05 Mn | 80.05 Mn | - | 2.27 Mn |
| 10 | Drugs Made In America Acquisition | 1.46 Mn | 1.46 Mn | - | 2.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.30 Mn |
| Sep 30, 2025 | 2.45 Mn |
| Jun 30, 2025 | 2.42 Mn |